Your browser doesn't support javascript.
loading
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer.
Cohn, A L; Tabernero, J; Maurel, J; Nowara, E; Sastre, J; Chuah, B Y S; Kopp, M V; Sakaeva, D D; Mitchell, E P; Dubey, S; Suzuki, S; Hei, Y-J; Galimi, F; McCaffery, I; Pan, Y; Loberg, R; Cottrell, S; Choo, S-P.
Afiliação
  • Cohn AL; Rocky Mountain Cancer Center, Denver, USA. Electronic address: allen.cohn@usoncology.com.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona.
  • Maurel J; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Nowara E; Maria Skodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland.
  • Sastre J; Hospital Clinico San Carlos, Servicio de Oncologíca Medíca, Madrid, and Instituto Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain.
  • Chuah BYS; Department of Internal Medicine, National University Hospital, Singapore, Singapore.
  • Kopp MV; Samara Regional Oncology Dispensary, Samara.
  • Sakaeva DD; Clinical Oncology Dispensary of the Republic of Bashkortostan, Ufa, Russia.
  • Mitchell EP; Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia.
  • Dubey S; Amgen Inc., South San Francisco.
  • Suzuki S; Amgen Inc., South San Francisco.
  • Hei YJ; Amgen Inc., Thousand Oaks.
  • Galimi F; Amgen Inc., Thousand Oaks.
  • McCaffery I; Amgen Inc., Thousand Oaks.
  • Pan Y; Amgen Inc., Seattle, USA.
  • Loberg R; Amgen Inc., Thousand Oaks.
  • Cottrell S; Amgen Inc., Seattle, USA.
  • Choo SP; Medical Oncology, National Cancer Centre Singapore, Singapore.
Ann Oncol ; 24(7): 1777-1785, 2013 Jul.
Article em En | MEDLINE | ID: mdl-23510984
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas / Proteínas ras / Neoplasias Hepáticas Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas / Proteínas ras / Neoplasias Hepáticas Idioma: En Ano de publicação: 2013 Tipo de documento: Article